Status:
UNKNOWN
Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy
Lead Sponsor:
Cairo University
Conditions:
Myomectomy
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
the aim of the present study is to compare safety and efficacy of intravenous tranexamic acid versus IV carbetocin in reducing blood loss during abdominal myomectomy: a randomized controlled trial
Eligibility Criteria
Inclusion
- women with symptomatic fibroids candidate for abdominal myomectomy with staging of myoma from (3 to 6) according to FIGO staging
Exclusion
- women with Myoma FIGO staging (1,2,7 and 8) candidate for laparoscopic or hysteroscopic myomectomy, women with allergy or contraindications to carbetocin or tranexamic acid
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 20 2020
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04357015
Start Date
May 1 2020
End Date
October 20 2020
Last Update
April 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.